MC Services is thrilled to be media partner of the 30th anniversary edition of BIO-Europe®, Europe’s must-attend partnering event for executives and decision-makers in the biotech and pharma industries. The event, organized by EBD Group, will take place in Stockholm, Sweden, November 4-6, 2024, followed by a digital partnering edition November 12-13, 2024.
“As we celebrate three decades of fostering partnerships in the biopharma community at BIO-Europe, it is particularly meaningful to do so in Stockholm – home of the Nobel Prize and a thriving hub for life sciences innovation and technology. With its strong tradition of excellence in science and research, Stockholm is at the forefront of biotech and healthcare, supported by world-class institutions and a vibrant startup ecosystem”, said Anne Hennecke, Managing Partner of MC Services. “We are proud to serve as media partner for EBD’s milestone event and at the same time celebrate MC Services’ 25th anniversary by leveraging our carefully cultivated and well-established network to amplify the voices and ideas shaping the future of our industry.
BIO-Europe 2024 celebrates 30 years of shaping the life sciences industry through transformative deals and partnerships. Expert-led panels will review past achievements and examine future opportunities, with a particular focus on regulatory trends and the application of AI in drug development.
The conference is set to bring together over 5,500 executives from biotech and pharma companies as well as stakeholders in the financial community from 60+ countries. Additionally, the event will feature three days of program sessions, which have been built around three themes: the Business of Biotech, Therapeutic Insights and Ecosystem Innovation.
Other highlights include:
Monday, 04 November:
10:00 – 12:00 Europe-China Biotech Business Forum 2024. Discover how China’s robust ecosystem, innovation and flexible collaboration models are empowering European Biotechs to thrive. Featuring two panels of internationally recognized leaders in Biotech with a questions and answer session
11:00 – 11:30 “Voulez-Vous?” Investing in a sustainable future with global pharma, featuring Magnus Björsne, Executive Director AstraZeneca BioVenture Innovation Unit, CEO AstraZeneca BioVentureHub AB. Discover the pharmaceutical industry’s efforts to reduce its carbon footprint through sustainable practices, innovative approaches, and circular economy principles to foster long-term growth and address environmental and social responsibilities.
15:00 – 16:30 Merck’s EMEA Advance Biotech Grant at BIO-Europe. Merck’s EMEA Advance Biotech Grant Program supports emerging biotech companies by offering a competition where five selected finalists pitch their innovations to Merck’s Grant representatives and the BIO-Europe audience, aiding their path to commercialization.
Tuesday, 05 November:
10:00 – 10:30 “Keep An Eye On Dan” – Navigating the biopharma services landscape: current trends and future perspectives, with Dan Stanton, Managing Editor, Bioprocess International and Benedikt von Braunmühl, CEO Rentschler Biopharma. The BioProcess Insider editorial team engages a panel of experts to discuss how quarterly shifts in the pharma industry, including global events, deal-making, and regulatory advancements, are impacting the bio services space and key industry developments.
Business of Biotech TVM Capital Life Science Sponsored AI track: Moderated by Dr. Hubert Birner, Managing Partner
15:30 – 16:00 “The Name of the Game”: Why is AI crucial for the future of the biopharma industry?, featuring Verena Schustereder, Customer Engineer Manager, EMEA North, Google Europe. Discover how AI is more than just a trend, emerging as a transformative force revolutionizing the future of healthcare and biopharma, with far-reaching impacts on research, development, and patient care.
16:00 – 16:30 “I Have a Dream” AI for drug discovery, with Lovisa Afzelius, General Partner Flagship Pioneering, Stephan Brock, Molecular Health, Michelle Chen, CBO Insilico Medicine, Tim James, VP and Head of In Silico R&D Evotec, Hartmut Juhl, CEO Indivumed GmbH and Maria Luisa Pineda, Vice Chair, Cofounder and Board Member Envisagenics. Explore how AI algorithms are transforming the discovery and development of novel therapeutics, as industry experts discuss the latest advancements, challenges, and emerging opportunities in this innovative field.
16:30 – 17:00 “Why Did It Have to Be Me?”: AI for Diagnosis, with Prof. Ralf Huss, Pathologist, CEO of BioM, Former CSO of Definiens AG, David Krummen, Co-Founder, Vektor Medical and Peter Vanovertfeld, Co-CEO, Smart Reporting. Explore how AI-driven technologies are revolutionizing medical diagnostics, enhancing accuracy, efficiency, and patient outcomes. Gain valuable insights from experts on the latest developments, challenges, and future prospects in leveraging AI for diagnostic purposes.
Wednesday, 06 November:
11:00 – 11:45 “Thank You for the Music”: Key takeaways from BIO-Europe’s 30th anniversary! Join us for a comprehensive recap of BIO-Europe 2024, featuring event highlights, fresh perspectives, and key insights from speakers and participants. As we gear up for BIO-Europe 2025, we’re excited to welcome you to Vienna! The conference provides plenty of networking opportunities with experts at leading pharma and biotech companies, sharing their knowledge on the latest innovations and global trends of the industry.
For more information regarding the program, timing and additional activities, please visit the event’s website.
As a media partner, MC Services is happy to invite local and international journalists to attend the event and supports them by organizing interviews with senior executives from life science companies and investors. We will be on site throughout the conference to support successful outcomes and provide a pleasant working environment at the event’s press lounge.